Anti Kickback The EpiPen Whistleblower Saga Comes to a Close Thomas Sullivan Aug 31, 2017 0 Last week, Mylan Inc. and Mylan Specialty L.P. (hereinafter “Mylan”) reached an agreement with the United States Department of…
Life Science Compliance Update A New Application of Escobar: Gilead or When Half-Truths Can Become… Thomas Sullivan Aug 31, 2017 0 On July 7, 2017, the Ninth Circuit in a very closely watched opinion determined that the whistleblowers in this case had…
